The data is in
The College is pleased to announce the latest update of Asthma Management and the Allergist: Better Outcomes at Lower Cost. This College publication, also know…
Drug-induced anaphylaxis, mast cell activation syndrome and the ICON on ocular allergy
The days are getting longer as we get closer to the spring allergy season. Although our emphasis in this month’s issue of the Annals of Allergy, Asthma and Imm…
Are you informed about informed consent?
Pop quiz: what is informed consent, when is it required for allergy practices, and how exactly should it be done? Some physicians and practices have adopted a …
A new era in allergy treatment
As we enter a new era in allergy treatment with the release of the first Food and Drug Administration (FDA)-approved product to treat peanut allergy, I wanted …
The College’s revitalized House of Delegates
We’re reinvigorating the College's House of Delegates (HOD) to provide a closer connection between the College/Advocacy Council and member allergists…
February’s issue of Annals focuses on anaphylaxis
Groundhog Day came and went, and the little guy did not see his shadow, which means an early spring. Many of us are gearing up for the seasonal rush that we al…

In memoriam: Gary Hein
We were saddened to learn that Gary Hein, founder of Lincoln Diagnostics, passed away on Feb. 2. Several members gave tributes to Gary.Entrepreneur, businessma…
New Principal Care Management CPT Codes
The Centers for Medicare and Medicaid Services (CMS) has approved two new Principal Care Management (PCM) CPT codes for 2020 that may apply to allergists treat…
From the Desk of the EMD: Remote practice of allergy – what can you do?
One of the most common emails that the College receives from members is “Why can’t the College do something about the remote practice of allergy?&r…
The latest salary, practice cost and revenue data
The 2019 survey results are in, and we’ve got financial data on allergist compensation as well as practice costs and revenue.The College’s continued partnershi…
